<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05102851</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-07-05</org_study_id>
    <nct_id>NCT05102851</nct_id>
  </id_info>
  <brief_title>Impact of Prediabetes on Acute Coronary Syndrome</brief_title>
  <official_title>Impact of Prediabetes On Acute Coronary Syndrome in Sohag University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes mellitus is one of the chronic non-communicable diseases which have emerged as a&#xD;
      leading global health problem. According to the International Diabetes Federation Atlas&#xD;
      guideline report, currently, there are 352 million adults with impaired glucose tolerance who&#xD;
      are at high risk of developing diabetes in the future. In 2017, it was estimated that 425&#xD;
      million people (20-79 years of age) suffered from Diabetes mellitus, and the number is&#xD;
      expected to rise to 629 million by 2045. Moreover, Egypt is considered one of the top 10&#xD;
      countries in the world&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute Coronary Syndrome refers to a constellation of symptoms compatible with acute&#xD;
      myocardial ischemia. The syndrome includes systolic time segment elevation myocardial&#xD;
      infarction non-systolic time segment elevation myocardial infarction and unstable angina.&#xD;
&#xD;
      Patients have an over tenfold risk for cardiovascular disease in their lifetime. In the&#xD;
      United States, 77% of diabetes-related hospital admissions are for cardiovascular&#xD;
      complications. A key feature of diabetes contributing to this is the development of&#xD;
      accelerated atherosclerosis.&#xD;
&#xD;
      Prediabetes is a collective term that encloses individuals with glucose levels lower than&#xD;
      cutoff levels for diabetes but too high to be considered normal. Fasting blood glucose 6.1&#xD;
      mmol/L- &lt;7.0 mmol/L. In impaired glucose tolerance the ranges of blood glucose are&gt;7.8&#xD;
      mmol/L-&lt;11.1 mmol/L4.&#xD;
&#xD;
      Prediabetes is associated with a significant increase in cardiovascular morbidity and&#xD;
      mortality and necessitates early and adequate intervention to prevent the development of&#xD;
      complications, and progression to overt diabetes.&#xD;
&#xD;
      Higher fasting glucose levels in patients with the acute coronary syndrome were associated&#xD;
      with worse clinical outcomes irrespective of the presence of diabetes mellitus. Similarly,&#xD;
      higher fasting glucose was a marker of adverse outcomes in patients without diabetes&#xD;
      presenting with acute systolic time segment elevation myocardial infarction.&#xD;
&#xD;
      Impaired glucose tolerance is common among non-diabetic patients admitted with the acute&#xD;
      coronary syndrome. However, evidence is controversial regarding the prognostic impact of&#xD;
      'prediabetes' on the clinical outcome&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 11, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Hba1c</measure>
    <time_frame>Day 1</time_frame>
    <description>We consider patients with Hba1c less than 5.7% not diabetic , Patients with Hba1c from 5.7%-6.4% prediabetic and patients with Hba1c 6.5% or more diabetic patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CCU admission</measure>
    <time_frame>6 months</time_frame>
    <description>All patients admitted with acute coronary syndrome will be included in the research</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Diabetic Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Patient with acute coronary syndrome</arm_group_label>
    <description>All patients with the acute coronary syndrome were included in the study. Pre-diabetic patient. Non-diabetic patient(Controlled)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Troponin, Lipid profile, HBA1C, Fasting blood glucose level, Creatinine, Body Mass Index</intervention_name>
    <description>Full history: age, sex, smoking, known diabetes, positive family history high serum creatinine, history of prior percutaneous coronary intervention (PCI) or coronary arteries bypass grafting (CABG), or acute coronary syndrome (ACS). hypertension, diet.</description>
    <arm_group_label>Patient with acute coronary syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Statistical presentation and analysis of the present study will be conducted SPSS V.22.&#xD;
        Data will be expressed into phases:&#xD;
&#xD;
        Ι- Descriptive Mean value(X) and Standard Deviation (SD): for quantitative data. Frequency&#xD;
        and percentage for qualitative data.&#xD;
&#xD;
        Π- Analytic by t-student test and Chi-square test. P value &gt;0.05 will be considered&#xD;
        statistically non-significant. P value ≤0.05 will be considered statistically significant.&#xD;
&#xD;
        P value ≤0.001 will be considered statistically highly significant. Variance: Correlation&#xD;
        of MPV with other parameters was performed by Pearson correlation test (r value as the&#xD;
        coefficient).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with acute coronary syndrome&#xD;
&#xD;
          -  Diabetic patients and will be subdivided into controlled and uncontrolled Pre-diabetic&#xD;
             patients.&#xD;
&#xD;
          -  Non-diabetic patient(Controlled)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under 18 years old&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Chronic kidney disease&#xD;
&#xD;
          -  Familiar hyperlipidemia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amal K. Ahmed, Ass. Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Sohag University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hany A. Muhammed Khalil, Lecturer</last_name>
    <role>Study Chair</role>
    <affiliation>Sohag University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dina A. Elameer, M.B.B.Ch</last_name>
    <phone>+201092580652</phone>
    <email>dinaabdelnasser@med.sohag.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sohag University</name>
      <address>
        <city>Sohag</city>
        <zip>82524</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina A. Elameer, M.B.B.Ch</last_name>
      <phone>+0201092580652</phone>
      <email>dinaabdelnasser@med.sohag.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Dina Abdelnasser Elamir</investigator_full_name>
    <investigator_title>Resident doctor at Internal Medicine department, Sohag University Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Diabetic Cardiomyopathies</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

